Dr. Gary Gibbons, Director of the NIH National Heart, Lung, and Blood Institute, discusses sickle cell disease (SCD), efforts that prompted SCD progress in the U.S. and globally, and the latest advances in therapeutics, potential
More: Alliance Discussion with Gary Gibbons, MD: Hope in The Fight Against Sickle Cell DiseaseJohn Crowley, Chairman and CEO of Amicus Therapeutics, discussed his personal journey with rare disease research, developing novel treatments, centering patient advocacy, and overcoming innovation barriers.
More: Alliance Discussion with John Crowley: An Innovative, Patient-Centered Approach to Rare DiseasesGenomic testing can drastically reduce the waiting time in the diagnosis of genetic disorders, not only saving lives, but money. These services, including rapid whole genome sequencing (rWGS), should be a standard of care for
More: Rapid Whole Genome Sequencing: The High-Tech Solution to Lowering Infant Mortality (And Reducing Medical Costs, Too)
